| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Keros Therapeutics, Inc. (KROS) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 50 sells. KROS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 759.2K | $8.84M | - | |
| Dir | 759.2K | $8.84M | - | |
| Dir | 150.0K | $1.75M | - | |
| CEO | 62.5K | $727.5K | - | |
| Dir | 14.8K | $172.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2022 | Lachey Jennifer69 | Chief Scientific Officer | Sale+OE | 5,300 | $41.90 | $222,049.61 | -1.2% | -11.9% | +6.8% | |
| Apr 11, 2022 | Lachey Jennifer69 | Chief Scientific Officer | Sale+OE | 5,300 | $62.77 | $332,704.52 | -1.5% | -55.1% | -39.8% | |
| Apr 6, 2022 | Rovaldi Christopher | Chief Operating Officer | Sale+OE | 1,728 | $65.00 | $112,320.00 | -100% | -56.5% | -39.5% | |
| Apr 4, 2022 | Lachey Jennifer69 | Chief Scientific Officer | Sale+OE | 7,950 | $60.00 | $477,000.00 | -8.5% | -54.2% | -33.5% | |
| Apr 1, 2022 | Rovaldi Christopher | Chief Operating Officer | Sale+OE | 864 | $57.49 | $49,675.08 | -28.2% | -53.5% | -28.2% | |
| Mar 11, 2022 | Lachey Jennifer69 | Chief Scientific Officer | Sale+OE | 2,650 | $53.38 | $141,448.84 | -1.0% | -40.4% | -14.5% | |
| Feb 11, 2022 | Lachey Jennifer69 | Chief Scientific Officer | Sale+OE | 2,650 | $52.06 | $137,964.70 | -1.0% | -19.4% | +4.0% | |
| Jan 11, 2022 | Lachey Jennifer69 | Chief Scientific Officer | Sale+OE | 2,650 | $53.75 | $142,447.26 | -1.0% | +14.3% | -11.7% | |
| Jan 5, 2022 | Lachey Jennifer69 | Chief Scientific Officer | Sale+OE | 2,650 | $60.00 | $159,000.00 | -3.0% | +12.3% | -18.8% | |
| Jan 5, 2022 | Knowles Julius62 | Director | Sell | 47,651 | $57.84 | $2,756,115.99 | -0.7% | +12.3% | -18.8% |